Everson GT, Terrault N, Lok AS, Brown RS, Saab S, Shiffman ML, Al-Osiami AM, Kulik LM, Gillespie BW, Everhart JE, A2ALL Study Group. Interim analysis of a controlled trial of pre-transplant peginterferon alfa-2b/ribavirin (PEG/RBV) to prevent recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) in the adult-to-adult liver transplantation (A2ALL) study. Hepatology 2009 Sep 23;50(Suppl 4):302A.
